Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ACUTAAS CHEMICALS LTD.

NSE : ACUTAASBSE : 543349ISIN CODE : INE00FF01025Industry : Pharmaceuticals & DrugsHouse : Private

BSE1481.0555.7 (+3.91 %)

PREV CLOSE ( ) 1425.35

OPEN PRICE ( ) 1435.00

BID PRICE (QTY) 1480.75 (7)

OFFER PRICE (QTY) 1482.35 (60)

VOLUME 33069

TODAY'S LOW / HIGH ( )1410.70 1495.70

52 WK LOW / HIGH ( )696.02 1444.05

NSE1480.9056.3 (+3.95 %)

PREV CLOSE( ) 1424.60

OPEN PRICE ( ) 1435.00

BID PRICE (QTY) 1481.00 (1)

OFFER PRICE (QTY) 1481.60 (1)

VOLUME 432504

TODAY'S LOW / HIGH( ) 1412.00 1498.00

52 WK LOW / HIGH ( )696.75 1445

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-06 2007

Management Info

Nareshkumar Patel - Chairman Nareshkumar Patel - Managing Director

Registered Office

Address Plot No 440/5 & 6,Road No 82,G I D C Sachin,
Surat,
Gujarat-394230

Phone 7227977744 / 7573015366

Email info@acutaas.com

Website www.acutaas.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

11Jul Acutaas Chemicals informs about certif
Acutaas Chemicals has informed that it enclosed the certificate dated Ju..

04Jun Acutaas Chemicals informs about analys
Acutaas Chemicals has informed that the Company’s Officials will attend..

20May Kotak Mahindra Mutual Fund buys 6.6% s
Kotak Mahindra Mutual Fund (Kotak MF) has bought a 6.6 per cent stake in..

02May Ami Organics informs about audited fin
In accordance with Regulation 30 of SEBI (Listing Obligations and Disclo..

02May Ami Organics informs about press release
In accordance with Regulation 30 of the SEB! (Listing Obligation and Dis..

Financials

Rs. in Millions

	QTR Jun 25	ANNUAL 25
Net Profit	446.46	1595.47
Gross Profit	589.27	2135.76
Operating Profit	670.09	2434.78
Net Sales	2059.71	9898.35

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 14788.80 (1.25%)	M.Cap ( in Cr)18962.19
Astrazeneca Pharma I (BSE) 9152.90 (0.70%)	M.Cap ( in Cr)22875.00
Glenmark Pharma (BSE) 2050.05 (2.99%)	M.Cap ( in Cr)57879.39
Hester Biosciences (BSE) 2142.05 (2.16%)	M.Cap ( in Cr)1831.06
Blue Jet Healthcare (BSE) 744.20 (4.99%)	M.Cap ( in Cr)12909.30

Shareholding Pattern

	PROMOTERS	32.66%
	NON-INSTITUTION	28.01%
	MUTUAL FUNDS/UTI	16.27%
	FI/BANKS/INSURANCE	4.68%
	GOVERNMENT	0.01%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
SBI Healthcare Opp ...	2.97
Union Innovation & ...	2.78
Kotak Consumption F...	2.67
Bank of India ELSS ...	2.54
Union Small Cap Fun...	2.40
Samco Special Oppor...	2.29
Kotak Healthcare Fu...	2.27

Risk Disclosures on Derivatives

Smart Quotes

ACUTAAS CHEMICALS LTD.